Eric Moessinger is a Partner at +ND Capital, where he joined in 2008 as the first employee of the firm’s Silicon Valley. See sector focus and contact routes.
Eric Moessinger is a Partner at +ND Capital, where he joined in 2008 as the first employee of the firm’s Silicon Valley office, bringing prior experience as a consultant at Bain & Company and an MSc from The London School of Economics. He focuses specifically on life sciences investments, with a thesis centered on early-stage ventures in biotechnology and related healthcare sectors, primarily within the United States. While the firm’s typical check size and Moessinger’s lead versus follow behavior are not explicitly detailed in available sources, he has helped lead investments in companies such as Orca, Octant, and Nutcracker. His notable portfolio includes SQZ Biotech (now NYSE: SQZ), Twist Bioscience (Nasdaq: TWST), Emulate, and Visby Medical, many of which he has served on the board of or observed. Moessinger currently holds board positions at Emulate, Visby Medical, AIRNA, Partillion, and Osasuna, and previously served on boards of acquired firms like Icosavax (acquired by AstraZeneca) and Serotiny (acquired by Johnson & Johnson). No distinctive public writing or unique point of view from Moessinger is documented in the search results, limiting insight into
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in San Francisco when building a target list.
Investors like Eric Moessinger · Full investor directory · Investor access · Company funding database